GLP-1 Hair Loss: Why It Happens and How to Prevent It

GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) can be associated with hair shedding, but the drug is not directly poisoning your hair follicles. In the STEP 1 trial (NEJM 2021), about 3% of people taking semaglutide reported hair loss, compared with roughly 1% on placebo. With tirzepatide in the SURMOUNT-1 trial (NEJM 2022), hair loss was reported by around 5-7% of participants at higher doses, and notably it was more common in women.

The key insight from these trials is *why* it happens. Hair loss showed up most in people who lost the most weight, the fastest. This points to a condition called telogen effluvium — a temporary, reversible shedding triggered by physical stress on the body. Rapid weight loss, a sudden drop in calories, and shifting nutrition all act as that stressor. The medication is the tool that creates rapid weight loss; the weight loss itself is what nudges hair follicles into their shedding phase. This is the same reason people lose hair after childbirth, major surgery, high fever, or crash diets.

Telogen effluvium is the medical term for widespread temporary hair shedding. To understand it, picture your hair follicles cycling through three phases: anagen (active growth, where about 85-90% of your hairs normally sit), catagen (a brief transition), and telogen (resting, then shedding). Normally only about 10% of your hairs are resting at once, and you lose 50-100 per day without noticing.

When the body experiences a shock — in this case rapid weight loss and reduced nutrient intake — it prioritizes essential functions and pushes a larger share of follicles into the telogen resting phase early. A few months later, those hairs all shed together. That is why the shedding feels alarming and sudden: you may notice more hair in the shower drain or brush around the 3-4 month mark, well after you started the medication. The good news is that because the follicles are only resting, not destroyed, they almost always regrow. Telogen effluvium does not cause bald patches or a receding hairline the way genetic hair loss does; it is a diffuse, all-over thinning that recovers.

The single most protective step is getting enough protein. When appetite drops sharply on a GLP-1, many people unintentionally eat too little protein, which starves hair follicles of the amino acids they need. Aim for roughly 0.6-0.8 grams of protein per pound of your goal body weight per day, spread across meals. Prioritizing protein also protects muscle, which matters for the same reason — you can read more in our guide on [protein needs on GLP-1](/blog/protein-needs-on-glp1-during-menopause-prevent-muscle-loss).

Beyond protein, watch key micronutrients. Iron deficiency is one of the most common nutritional causes of hair shedding, especially in women who still menstruate. Zinc, vitamin D, and biotin also support the hair cycle. Because GLP-1s reduce how much you eat overall, deficiencies are easier to develop — see our overview of [micronutrient deficiencies on GLP-1](/blog/micronutrient-deficiencies-on-glp1-what-to-watch-for). Finally, ask your provider about a slower dose titration. Escalating the dose more gradually keeps weight loss steady rather than dramatic, which reduces the metabolic shock that triggers telogen effluvium in the first place.

For the large majority of people, hair regrows on its own within six months of the shedding slowing down. Because telogen effluvium is a resting-phase problem rather than follicle destruction, the follicles simply resume their normal growth cycle once your weight and nutrition stabilize. You may first notice short, wispy regrowth hairs framing your hairline — a reassuring sign the cycle has reset.

Regrowth tends to line up with weight maintenance. Once you reach a stable weight and are no longer in a steep calorie deficit, the stressor is gone and follicles recover. If shedding continues past 9-12 months, is patchy, or comes with scalp symptoms like redness or itching, that is a reason to see a dermatologist, because something other than telogen effluvium may be involved — such as thyroid dysfunction, iron-deficiency anemia, or genetic hair loss that was already developing. This matters especially in midlife, when menopause-related hair thinning can overlap; our article on [menopause hair loss](/blog/menopause-hair-loss-thinning-causes-and-what-helps) covers that distinction.

For most people, hair loss alone is not a reason to stop a GLP-1 medication, because it is temporary and the cardiometabolic benefits of the drug are substantial and lasting. The SELECT trial (NEJM 2023) showed semaglutide reduced major cardiovascular events by about 20% in people with overweight and existing heart disease, and GLP-1s meaningfully improve blood sugar, blood pressure, and sleep apnea. Those benefits generally outweigh temporary shedding.

That said, this is a personal decision, and hair loss can be genuinely distressing. If it is affecting your mental health, talk to your provider about options short of stopping: slowing your dose escalation, tightening up protein and micronutrient intake, or checking labs (ferritin, TSH, vitamin D) to rule out a treatable cause. Some people also find that supporting regrowth cosmetically — gentle styling, volumizing products, and avoiding tight hairstyles or high heat — helps them get through the peak-shedding months. The goal is to ride out a temporary phase without giving up a medication that is doing important work for your long-term health.